<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">High aminopeptidase A activity contributes to blood pressure control in ob/ob mice by AT 2 receptor-dependent mechanism</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-12-09">December 9, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Rafael</forename><forename type="middle">L</forename><surname>Morais</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Departamento de Biofísica</orgName>
								<orgName type="institution">Universidade Federal de São Paulo</orgName>
								<address>
									<addrLine>Campus São Paulo</addrLine>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Aline</forename><forename type="middle">M</forename><surname>Hilzendeger</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Departamento de Biofísica</orgName>
								<orgName type="institution">Universidade Federal de São Paulo</orgName>
								<address>
									<addrLine>Campus São Paulo</addrLine>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bruna</forename><surname>Visniauskas</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Departamento de Psicobiologia</orgName>
								<orgName type="institution">Universidade Federal de São Paulo</orgName>
								<address>
									<addrLine>Campus São Paulo</addrLine>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mihail</forename><surname>Todiras</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Max-Delbrück-Center for Molecular Medicine</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Natalia</forename><surname>Alenina</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Max-Delbrück-Center for Molecular Medicine</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marcelo</forename><forename type="middle">A</forename><surname>Mori</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Departamento de Biofísica</orgName>
								<orgName type="institution">Universidade Federal de São Paulo</orgName>
								<address>
									<addrLine>Campus São Paulo</addrLine>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ronaldo</forename><forename type="middle">C</forename><surname>Araújo</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Departamento de Biofísica</orgName>
								<orgName type="institution">Universidade Federal de São Paulo</orgName>
								<address>
									<addrLine>Campus São Paulo</addrLine>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Clovis</forename><forename type="middle">R</forename><surname>Nakaie</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Departamento de Biofísica</orgName>
								<orgName type="institution">Universidade Federal de São Paulo</orgName>
								<address>
									<addrLine>Campus São Paulo</addrLine>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jair</forename><forename type="middle">R</forename><surname>Chagas</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Departamento de Psicobiologia</orgName>
								<orgName type="institution">Universidade Federal de São Paulo</orgName>
								<address>
									<addrLine>Campus São Paulo</addrLine>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Adriana</forename><forename type="middle">K</forename><surname>Carmona</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Departamento de Biofísica</orgName>
								<orgName type="institution">Universidade Federal de São Paulo</orgName>
								<address>
									<addrLine>Campus São Paulo</addrLine>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Bader</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Max-Delbrück-Center for Molecular Medicine</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">Charité University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">German Center for Cardiovascular Research</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Institute for Biology</orgName>
								<orgName type="institution">University of Lübeck</orgName>
								<address>
									<settlement>Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">João</forename><forename type="middle">B</forename><surname>Pesquero</surname></persName>
							<email>jbpesquero@gmail.com</email>
							<affiliation key="aff0">
								<orgName type="department">Departamento de Biofísica</orgName>
								<orgName type="institution">Universidade Federal de São Paulo</orgName>
								<address>
									<addrLine>Campus São Paulo</addrLine>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Departamento de Biofísica</orgName>
								<orgName type="institution">Universidade Federal de São Paulo -UNIFESP</orgName>
								<address>
									<settlement>São Paulo</settlement>
									<region>SP</region>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">High aminopeptidase A activity contributes to blood pressure control in ob/ob mice by AT 2 receptor-dependent mechanism</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-12-09">December 9, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">6284F879C6FDFCF0FB9E445CA5A321D7</idno>
					<idno type="DOI">10.1152/ajpheart.00485.2016</idno>
					<note type="submission">Submitted 11 July 2016; accepted in final form 6 December 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:30+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Obesity is assumed to be a major cause of human essential hypertension; however, the mechanisms responsible for weight-related increase in blood pressure (BP) are not fully understood.</s><s>The prevalence of hypertension induced by obesity has grown over the years, and the role of the renin-angiotensin-aldosterone system (RAAS) in this process continues to be elucidated.</s><s>In this scenario, the ob/ob mice are a genetic obesity model generally used for metabolic disorder studies.</s><s>These mice are normotensive even though they present several metabolic conditions that predispose them to hypertension.</s><s>Although the normotensive trait in these mice is associated with the poor activation of sympathetic nervous system by the lack of leptin, we demonstrated that ob/ob mice present massively increased aminopeptidase A (APA) activity in the circulation.</s><s>APA enzyme metabolizes angiotensin (ANG) II into ANG III, a peptide associated with intrarenal angiotensin type 2 (AT2) receptor activation and induction of natriuresis.</s><s>In these mice, we found increased ANG-III levels in the circulation, high AT2 receptor expression in the kidney, and enhanced natriuresis.</s><s>AT2 receptor blocking and APA inhibition increased BP, suggesting the ANG III-AT2 receptor axis as a complementary BP control mechanism.</s><s>Circulating APA activity was significantly reduced by weight loss independently of leptin, indicating the role of fat tissue in APA production.</s><s>Therefore, in this study we provide new data supporting the role of APA in BP control in ob/ob mouse strain.</s><s>These findings improve our comprehension about obesity-related hypertension and suggest new tools for its treatment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NEW &amp; NOTEWORTHY</head><p><s>In this study, we reported an increased angiotensin III generation in the circulation of ob/ob mice caused by a high aminopeptidase A activity.</s><s>These findings are associated with an increased natriuresis found in these mice and support the role of renin-angiotensin-aldosterone system as additional mechanism regulating blood pressure in this genetic obese strain.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>aminopeptidase A; hypertension; obesity; renin-angiotensin-aldosterone system; ob/ob mice HYPERTENSION IS A SERIOUS health problem and a major risk factor for coronary heart and cerebrovascular disease <ref type="bibr" target="#b41">(40)</ref>.</s><s>Increased blood pressure (BP) is estimated to cause 7.5 million deaths per year worldwide <ref type="bibr" target="#b42">(41,</ref><ref type="bibr" target="#b43">42)</ref> and is also associated with heart failure, renal impairment, and damage to peripheral and retinal blood vessels <ref type="bibr">(9, 40 -42)</ref>.</s><s>In recent decades, the prevalence of hypertension has increased along with obesity cases, where excess of weight gain was associated with BP increase <ref type="bibr" target="#b7">(8,</ref><ref type="bibr" target="#b23">24)</ref>.</s></p><p><s>Obesity and hypertension are linked to the renin-angiotensin-aldosterone system (RAAS), a major regulator of BP, which controls body fluid and electrolyte homeostasis <ref type="bibr" target="#b12">(13,</ref><ref type="bibr" target="#b39">38)</ref>.</s><s>RAAS is activated in animals treated by high-fat diet (HFD), where increased angiotensin (ANG) II levels and high BP are observed <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b11">12)</ref>.</s><s>RAAS inhibitors can normalize high BP caused by obesity in experimental models <ref type="bibr" target="#b4">(5)</ref>, as well as in humans <ref type="bibr" target="#b19">(20)</ref>.</s><s>On the other hand, secondary effects of RAAS downregulation by pharmacological inhibition <ref type="bibr" target="#b31">(32)</ref> or genetic disruption <ref type="bibr" target="#b21">(22)</ref> include body weight and fat tissue loss.</s><s>The connection between RAAS and metabolism has narrowed over the years with fat tissue as a major factor for hypertension development <ref type="bibr" target="#b44">(43)</ref>.</s><s>In this scenario, aminopeptidase A (APA) is a membrane-bound and soluble enzyme component of RAAS <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b15">16</ref>) that cleaves the NH 2 -terminal aspartate of ANG II to generate ANG III <ref type="bibr" target="#b29">(30,</ref><ref type="bibr" target="#b40">39)</ref>.</s><s>In past years, several studies related APA and hypertension <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b32">33)</ref>.</s><s>Recently, Kemp et al. <ref type="bibr" target="#b24">(25)</ref> demonstrated that intrarenal ANG III, but not ANG II or ANG-(1-7), induces natriuresis via activation of angiotensin type 2 (AT 2 ) receptors.</s><s>These data highlight the importance of APA in natriuresis by regulating the generation of ANG III from ANG II.</s></p><p><s>We investigated the regulation of APA expression and activity in the genetically obese strain ob/ob mouse.</s><s>As already shown in previous studies, ob/ob mice do not develop hypertension, despite several metabolic conditions favoring BP increase such as severe obesity <ref type="bibr" target="#b18">(19,</ref><ref type="bibr" target="#b25">26)</ref>, dyslipidemia, hyperinsulinemia, hyperglycemia, and insulin resistance <ref type="bibr" target="#b14">(15,</ref><ref type="bibr" target="#b27">28)</ref>.</s><s>Although the poor sympathetic nervous system (SNS) activation explains part of the normotensive trait observed in these animals <ref type="bibr" target="#b17">(18)</ref>, here we demonstrated that ob/ob mice present significantly increased APA activity in the blood, which would be a possible mechanism counteracting the elevation of ANG II in severe obesity <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b11">12)</ref>.</s><s>However, the regulation of APA activity is not entirely understood.</s></p><p><s>In this study, we demonstrated that APA activity in ob/ob mice is highly increased when compared with their lean control.</s><s>Body weight changes were able to regulate APA activity in the circulation, which suggests the role of fat tissue in this process.</s><s>As a result of high APA activity, ANG III levels were elevated in the circulation of ob/ob mice, together with enhanced natriuresis and AT 2 receptor expression in kidney.</s><s>AT 2 receptor blocking and APA inhibition increased BP, indicating their role in BP control.</s><s>Therefore, we propose that increased APA activity in ob/ob mice could be an additional mechanism regulating BP in these obese mice, in which ANG III-AT 2 receptor axis activation promotes increased sodium excretion.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head><p><s>Animals.</s><s>We used adult 16-wk-old male ob/ob, ob/ϩ wild-type (WT) C57Bl/6 mice purchased from CEDEME, the animal house of Universidade Federal de São Paulo (UNIFESP).</s><s>The apolipoprotein E (apoE Ϫ/Ϫ )-deficient mice were purchased from the Jackson Laboratory.</s><s>Animals were maintained on 12-h:12-h light-dark cycle at 22°C with free access to standard chow and water.</s><s>The experimental protocols and procedures were submitted and approved by the local Institutional Ethical Committee (0205/2010).</s><s>The protocols and pro-cedures are in accordance with the National Institutes of Health guide for the care and use of laboratory animals.</s></p><p><s>Measurement of APA activity.</s><s>Mouse serum was collected and stored at Ϫ80°C until use.</s><s>Total tissue was collected and immediately homogenized in cold buffer A, consisting of 50 mM Tris•HCl and 4 mM CaCl2; pH 7.4, and centrifuged at 10,000 g for 15 min at 4°C; the supernatant was stored at Ϫ80°C.</s><s>APA activity assessment was performed by fluorescence measurement (ex ϭ 340 nm and em ϭ 410 nm) followed by hydrolysis of specific substrate glutamyl ␤-naphthylamide (Glu-␤NA, Bachem).</s><s>Basically, an aliquot of homogenized tissue or mouse serum was incubated with buffer A and 20 M of Glu-␤NA substrate at 37°C under agitation for 20 min.</s><s>The fluorescence was detected and analyzed by spectrofluorometer (Spec-traMax Gemini XS, Molecular Devices).</s><s>The fluorescence parameter was set as arbitrary fluorescence units.</s><s>Amastatin was used as inhibitor for APA activity at 10 M.</s></p><p><s>Real-time PCR.</s><s>Total RNA (2 g) was reverse-transcribed using M-MLV (Invitrogen) to cDNA as suggested by the manufacturer.</s><s>The reaction product was amplified by real-time PCR using the SYBR Green reaction kit (Thermo Scientific).</s><s>mRNA was quantified as relative value compared with the ␤-actin housekeeping gene.</s><s>Primers used for real-time PCR were as follows: murine APA forward primer 5=-ACAGTGTCTATCGGCTGAC-3= and reverse primer 5=-TCCTG-GCATCTGTTGGTTC-3=; murine ␤-actin forward primer 5=-GAAC-CCTAAGGCCAACCGTGAA-3= and reverse primer 5=-GACCA-GAGGCATACAGGGACAAC-3=; murine AT 1 receptor forward In vitro and in vivo leptin treatment.</s><s>For in vitro actions of leptin in APA activity, sera from ob/ob and ob/ϩ mice were incubated with 200 ng/ml of leptin (R&amp;D Systems) or diluent (control group) for 1 h.</s><s>For acute leptin treatment in vivo, ob/ob mice were injected intravenously with leptin (1 mg/kg) or saline.</s><s>After 1 h, the serum was collected for analysis.</s><s>For chronic leptin treatment, ob/ob mice were treated daily with intraperitoneal leptin injections (1 mg/kg) or saline for 21 days.</s><s>The mice were weighed before and after the treatment to verify the effective weight loss.</s><s>After the treatment, the animals were euthanized and the sera and tissues were collected for further analysis.</s></p><p><s>Food restriction treatment.</s><s>Ob/ob mice were put in food restriction treatment or free food access (ad libitum) for 12 wk.</s><s>Each mouse was put in an individual cage and was weighted weekly.</s><s>For the first 3 wk mice from the restriction group received 30% less food.</s><s>After 3 wk the food restriction was set to 50% less food until 12 wk of treatment.</s><s>Food restriction calculation was based on average daily consumption for each mouse for 7 days before treatment.</s><s>After the treatment mice were euthanized for serum and tissue collection.</s></p><p><s>High-fat diet treatment.</s><s>Wild-type C57BL/6 mice 12-wk-old were fed ad libitum for 12 wk with control diet (10% kcal from fat) or HFD (60% kcal from fat), both commercial diets (Research Diets).</s><s>Each mouse was put in an individual cage and was weighted weekly.</s><s>After the treatment mice were euthanized for serum and tissue collection.</s></p><p><s>LC-MS/MS-based quantification of circulating angiotensin peptide levels.</s><s>Mice were anesthetized with isoflurane.</s><s>After full anesthesia effect, 500 l of blood were directly collected from the heart and put in an ice-cold, 1.5-ml tube containing the cocktail inhibitors.</s><s>Plasma was obtained after 2,000 g centrifugation for 10 min at 4°C and stored at Ϫ80°C until analysis.</s><s>Circulating angiotensin metabolites concentrations were determined by mass spectrometry using plasma samples collected in the presence of an inhibitor cocktail completely blocking angiotensin metabolism containing ethylenediaminetetraacetic acid, pepstatin A, p-hydroxymercuribenzoic acid, phenanthroline, serine proteases, and specific inhibitors for renin and aminopeptidases A and N to a final concentration of 5% vol/vol (Attoquant Diagnostics, Vienna, Austria).</s><s>Stabilized plasma (200 l) was spiked with stable isotope-labeled internal standards for each angiotensin metabolite, ANG I, ANG II, ANG-(1-7), ANG III, ANG IV, and ANG-(2-10) at a concentration of 200 pg/ml.</s><s>After C18-based solid-phase-extraction, samples were subjected to liquid chromatography-mass spectrometry/ mass spectrometry (LC-MS/MS) analysis by using a reversed-phase analytical column (Acquity UPLC C18, Waters) operating in line with a XEVO TQ-S triple quadrupole mass spectrometer (Waters) in multiple reaction monitoring mode.</s><s>Internal standards were used to correct for peptide recovery of the sample preparation procedure for each angiotensin metabolite in each individual sample.</s><s>Angiotensin concentrations were calculated considering the corresponding response factors determined in appropriate calibration curves, on condition that integrated signals exceeded a signal-to-noise ratio of 10.</s><s>The lower limit of quantification in picograms per milliliters of plasma for individual angiotensin metabolites were the following: ANG I ϭ 4, ANG II ϭ 3, ANG 1-7 ϭ 5.5, ANG III ϭ 3, ANG IV ϭ 2.8, and ANG 2-10 ϭ 4.</s></p><p><s>cGMP measurement.</s><s>For guanosine 3=,5=-cyclic monophosphate (cGMP) measurement, total mice kidney was homogenized and used as samples.</s><s>cGMP level was measured by a commercial kit (Cayman) with the whole procedure performed as specified by the manufacturer.</s></p><p><s>PD123319 and amastatin treatment.</s><s>Male ob/ob mice were injected intraperitoneally with saline (vehicle), 3 mg•kg Ϫ1 •day Ϫ1 of AT 2 receptor antagonist (PD123319, Abcam) or 3 mg•kg Ϫ1 •day Ϫ1 of APA inhibitor (Amastatin, Bachem) during 21 days.</s><s>BP was measured weekly, and at the end of the treatment, water consump-0.00E+00</s><s>Urine analysis and water consumption.</s><s>Mice were individualized and placed in metabolic cages for 24 h with ad libitum water and without food.</s><s>Urine was collected and the volume measured as well as water consumption for each animal.</s><s>After urine collection, sodium concentration was analyzed by an electrolyte analyzer (Roche AVL 9180), and the values were reported as milliequivalents per liter (mq/l).</s></p><p><s>Measurements of BP in conscious mice.</s><s>Male ob/ob mice were equipped with catheters in the femoral artery and vein by surgical procedure under chloral hydrate (400 mg/kg) anesthesia.</s><s>After a 48-h recovery period, the arterial catheter was connected to a pressure transducer (PowerLab, ADI Instruments) and mean arterial pressure was recorded under basal conditions.</s><s>The "tail cuff" method was used specifically for BP measurement in PD123319 and Amastatin treatments (PowerLab, ADI Instruments).</s></p><p><s>Statistical analysis.</s><s>Results were reported as means Ϯ SE.</s><s>Statistically significant differences in mean values were evaluated by independent Student t-tests when two groups were compared or ANOVA for more groups comparison.</s><s>A value of P Յ 0.05 was considered significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p><s>Ob/ob mice present higher APA activity in serum and kidney.</s><s>APA activity was quantified and a fivefold increase was observed in the serum of ob/ob mice when compared with that in control (Fig. <ref type="figure">1A</ref>).</s><s>The specificity of the assay was demonstrated by blocking the activity with amastatin, an APA inhibitor (Fig. <ref type="figure">1A</ref>).</s><s>Higher APA activity was observed in the kidney and lower activity in lung of ob/ob mice (Fig. <ref type="figure">1B</ref>).</s><s>Similarly, APA mRNA expression was also higher in kidney and lower in lung (Fig. <ref type="figure">1C</ref>).</s></p><p><s>Chronic leptin treatment reduces APA activity in ob/ob mice.</s><s>In this set of experiments we wanted to check whether the loss of leptin in ob/ob mice was directly involved in APA regulation.</s><s>Leptin was incubated with ob/ϩ and ob/ob mice serum in vitro, and no changes were observed in APA activity (Fig. <ref type="figure">2A</ref>).</s><s>In addition, when leptin was injected acutely in vivo in ob/ob mice, no effect on APA activity was observed (Fig. <ref type="figure">2B</ref>).</s><s>However, long-term leptin treatment reduced APA activity in the blood (Fig. <ref type="figure">2C</ref>) but not in kidney (Fig. <ref type="figure">2D</ref>).</s><s>As expected, chronic administration of leptin induced body weight loss in ob/ob mice (Fig. <ref type="figure">2E</ref>).</s></p><p><s>Body weight changes modulate APA activity in mice.</s><s>To evaluate whether APA activity reduction after leptin treatment was due to leptin or weight loss, we submitted ob/ob mice to a food restriction (FR) treatment for 12 wk (Fig. <ref type="figure">3A</ref>).</s><s>APA activity was decreased in animals after FR when compared with the free fed group (Fig. <ref type="figure">3B</ref>).</s><s>Conversely, body weight gain in HFD-treated WT mice (Fig. <ref type="figure">3C</ref>) increased APA activity in the circulation (Fig. <ref type="figure">3D</ref>).</s><s>As indi-   <ref type="figure">3E</ref>).</s></p><p><s>Cholesterol does not regulate APA activity in apoE Ϫ/Ϫ mice.</s><s>To investigate whether high-cholesterol levels were responsible for increased APA activity observed in ob/ob mice, we analyzed the serum of apoE Ϫ/Ϫ mice, which displayed significantly increased levels of plasma cholesterol.</s><s>However, no changes were observed in circulating APA activity and body weight in these mice, suggesting that cholesterol levels do not alter APA activity (Table <ref type="table" target="#tab_4">1</ref>).</s></p><p><s>ANG III peptide is elevated in the circulation of ob/ob mice.</s><s>The concentration of angiotensins was quantified in the circulation of ob/ob and ob/ϩ mice by LC-MS/MS technique.</s><s>The levels of ANG I, II, IV, 1-7, and 2-10 were not different when compared with ob/ϩ control mice (Figs. <ref type="figure" target="#fig_1">4, A-F</ref>).</s><s>However, in agreement to the higher APA activity in the circulation, we observed elevated levels of ANG III in the circulation of ob/ob mice (Fig. <ref type="figure" target="#fig_1">4C</ref>).</s></p><p><s>Normotensive ob/ob mice present increased natriuresis.</s><s>Ob/ob mice presented the same BP values as their ob/ϩ controls (Fig. <ref type="figure">5A</ref>).</s><s>Urine sodium excretion, urine volume, and water consumption were, however, increased in ob/ob mice (Figs. <ref type="figure">5, B-D</ref>).</s><s>AT 2 receptor mRNA expression (Fig. <ref type="figure">5F</ref>) and cGMP levels in the kidney were also significantly increased in ob/ob mice (Fig. <ref type="figure">5G</ref>).</s><s>These findings suggest an augmented AT 2 receptor activation in the kidney by the cGMP signaling, leading to an increased natriuresis in these mice.</s></p><p><s>AT 2 receptor blockade and APA inhibition increase BP in ob/ob mice.</s><s>Ob/ob mice presented increased BP and elevated natriuresis after 3 wk of treatment with the AT 2 blocker PD123319 when compared with vehicle (Figs. <ref type="figure" target="#fig_4">6, A and B</ref>).</s><s>Amastatin also increased BP in these mice after 3 wk of treatment (Fig. <ref type="figure" target="#fig_4">6E</ref>).</s><s>These data confirm the role of AT 2 receptor and APA as active mechanisms regulating BP in ob/ob mice.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Obesity is a major cause of human essential hypertension, but the mechanisms responsible for weight-related increase in BP are not fully understood.</s><s>The prevalence of hypertension induced by obesity has grown over the years <ref type="bibr" target="#b7">(8,</ref><ref type="bibr" target="#b23">24)</ref>, and the role of RAAS in this process continues to be elucidated <ref type="bibr" target="#b44">(43)</ref>.</s><s>In this scenario, the ob/ob mice are a genetic model of obesity generally used for metabolic disorder studies.</s><s>Despite the several factors favoring a BP increase in these mice, they do not develop hypertension and are considered normotensive <ref type="bibr" target="#b25">(26)</ref>.</s><s>To better elucidate this apparent paradox, we investigated the APA enzyme and its regulation in this mouse obese strain.</s></p><p><s>Recent studies reported the activation of the SNS in hypertension-associated obesity in which body weight gain correlates to SNS activation in experimental models and human subjects <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b17">18)</ref>.</s><s>Chronic leptin infusion causes sustained elevation in BP dependent on adrenergic receptor activation <ref type="bibr" target="#b5">(6)</ref>, exerting its effects on SNS through the melanocortin receptor 4 <ref type="bibr" target="#b6">(7,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b38">37)</ref>.</s><s>Thus the poor SNS activation caused by the lack of leptin could explain part of the ob/ob mice normotensive trait.</s><s>However, RAAS components also play an important role in BP regulation.</s><s>Our group has already described a reduced activity of angiotensin-converting enzyme (ACE) in the circulation of ob/ob mice <ref type="bibr" target="#b18">(19)</ref>, which also led to reduced efficiency of the ACE inhibitor enalapril.</s><s>Despite the low ACE activity, ANG I metabolism in ob/ob mice serum generated not only ANG II but also other metabolites lacking the NH 2terminal amino acids (data not shown).</s><s>A detailed analysis of these metabolites revealed a high-circulating APA activity in ob/ob mice, as well as a higher activity and gene expression in the kidney.</s></p><p><s>As already reported, exogenous administration of leptin can modulate ACE activity <ref type="bibr" target="#b18">(19)</ref>.</s><s>Here we show that leptin was unable to modulate APA activity in vitro or acutely in vivo; however, a long-term leptin treatment reduced its activity.</s><s>Chronic leptin treatment is known to reverse the phenotype found in ob/ob mice, including body weight and sterility <ref type="bibr" target="#b30">(31)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>H441</head><p><s>HIGH AMINOPEPTIDASE A ACTIVITY IN OB/OB MICE However, it remained unclear whether after leptin treatment, APA activity reduction was caused directly or indirectly by weight loss.</s><s>To answer this question, mice were submitted to a FR regimen for 12 wk, which resulted in decreased APA activity, independently of leptin.</s><s>Conversely, HFD increased APA activity proportionally with body weight gain.</s><s>Since body weight changes modulate several molecules related to metabolism, we decided to understand their correlation to APA activity.</s></p><p><s>Cholesterol has been described as modulator of APA activity in vitro <ref type="bibr" target="#b26">(27)</ref>; however, we failed to support these findings.</s><s>In our experiments, the apoE Ϫ/Ϫ mice, an atherosclerosis model, which presents elevated cholesterol levels in the circulation, displayed no changes in APA activity.</s><s>Accordingly, cholesterol had no effect in vitro on APA activity either (data not shown).</s><s>Although we found that cholesterol does not regulate APA activity, we hypothesized that fat tissue could be involved.</s><s>RAAS is described as functional in fat tissue and its participation is essential in hypertension development <ref type="bibr" target="#b44">(43)</ref>.</s><s>Thus we believe that fat loss after FR treatment is strongly associated to APA activity reduction in the circulation of ob/ob mice.</s><s>In the same way, body weight gain increased APA activity.</s><s>On the basis of these findings, we suggest that adipocytes could be a major source of circulating APA.</s><s>Nevertheless, it will require further investigations to better understand the mechanisms behind APA regulation.</s></p><p><s>In agreement with high APA activity, elevated levels of ANG III were also detected in the circulation of ob/ob mice.</s><s>Recently, it has been shown that intrarenal ANG III, but not ANG II or ANG (1-7), induces natriuresis via activation of AT 2 receptors in rats in a cGMP-dependent mechanism <ref type="bibr" target="#b24">(25)</ref>.</s><s>The authors suggested increasing ANG III levels generated by inhibition of aminopeptidase N (APN) could be a potential therapeutic approach to hypertension treatment.</s><s>In accordance with these findings, ob/ob mice presented increased renal expression of AT 2 receptor, increased cGMP levels in the kidney, and elevated natriuresis when compared with their lean controls.</s><s>AT 2 receptor blockade confirmed its role in BP regulation and promoted BP increase with low-sodium excretion, suggesting this pathway as an alternative mechanism for   <ref type="bibr" target="#b37">36)</ref>, indicating that at least in ob/ob mice, APA and AT 2 receptor represent an important role in BP regulation.</s><s>Therefore, we suggest that increased APA activity in the circulation, and in the kidney, could activate the ANG III-AT 2 receptor axis and induce Na ϩ output increase in this obese mouse strain.</s><s>However, there are still some pieces missing from this puzzle.</s><s>Studies with several populations worldwide have shown that excess of weight gain is predictable of future hypertension.</s><s>In fact, there seems to be an almost linear correlation between body mass index and BP <ref type="bibr" target="#b16">(17)</ref>.</s><s>However, this fact does not hold entirely true for ob/ob mice.</s><s>The lack of leptin signaling and SNS activation retains the normotensive trait observed in these animals, which seems to be also true for humans <ref type="bibr" target="#b34">(35)</ref>.</s><s>On the other hand, RAAS is a classical system known for BP control and APA is already described as a potential factor regulating BP increase in rodents.</s><s>In this sense, APA and candesartan, an AT 1 receptor blocker, produced the same effect on systolic BP when administrated intravenously in spontaneously hypertensive rats <ref type="bibr" target="#b20">(21)</ref>.</s><s>Also, APA knockout mice develop hypertension spontaneously and are more sensitive to ANG-II infusion <ref type="bibr" target="#b28">(29)</ref>.</s><s>Besides its effect on ANG II-AT 1 receptor axis, we suggest that the high-APA activity in ob/ob mice activates the ANG III-AT 2 receptor axis and induces increased natriuresis, as pointed out by our results.</s><s>Therefore, we propose that the massively increased APA activity found in ob/ob mice, together with their impaired SNS activation, are the main reason for the regular BP observed in this mouse strain.</s></p><p><s>In summary, this study presents new data regarding the APA regulation and its role on BP control.</s><s>These findings highlight the action of circulating APA in ANG-II metabolism and ANG-III generation in ob/ob mice, proposing an enhanced natriuresis as a complementary mechanism for BP control in these obese mice.</s><s>These data advance our understanding of RAAS and its complexity and suggest possible new tools for hypertension treatment.</s><s>H443</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 4 .</head><label>4</label><figDesc><div><p><s>Fig. 4. Angiotensins measurement by liquid chromatography-mass spectrometry/mass spectrometry in plasma of ob/ϩ and ob/ob mice.</s><s>Angiotensin I (A), angiotensin II (B), angiotensin III (C), angiotensin IV (D), angiotensin 1-7 (E), and angiotensin 2-10 (F) levels in plasma of ob/ϩ and ob/ob mice are shown.</s><s>Data are expressed as means Ϯ SE of picograms per milliliter.</s><s>**P Ͻ 0.01 ob/ob vs. ob/ϩ group; ns, not significant; ob/ϩ, n ϭ 4; ob/ob, n ϭ 4.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>ACKNOWLEDGMENTS</head><label></label><figDesc><div><p><s>We are grateful to our laboratory technicians Emanoel Barreto and Eduardo Spitti Resende for helping with the experiments.GRANTSThis work was supported by Fundação de Amparo a `Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.DISCLOSURESNo conflicts of interest, financial or otherwise, are declared by the author(s).AUTHORCONTRIBUTIONS R.L.M., A.M.H., B.V., M.T., N.A., and M.A.M. performed experiments; R.L.M., A.M.H., R.C.A., C.R.N., J.R.C., A.K.C., M.B., and J.B.P. analyzed data; R.L.M., R.C.A., C.R.N., J.R.C., A.K.C., M.B., and J.B.P. interpreted results of experiments; R.L.M., M.B., and J.B.P. prepared figures; R.L.M., M.B., and J.B.P. drafted manuscript; R.L.M., A.M.H., A.K.C., M.B., and J.B.P. edited and revised manuscript; R.L.M., A.M.H., B.V., M.T., N.A., M.A.M., R.C.A., C.R.N., J.R.C., A.K.C., M.B., and J.B.P. approved final version of manuscript.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 6 .</head><label>6</label><figDesc><div><p><s>Fig. 6.</s><s>AT2 receptor blockade and APA inhibition in ob/ob mice.</s><s>Mean arterial pressure (MAP) (A), sodium excretion (B), urine volume (C), and water consumption (D) after 3 wk of PD123319 treatment.</s><s>Mean arterial pressure (E), sodium excretion (F), urine volume (G), and water consumption (H) after 3 wk of amastatin treatment are shown.</s><s>Data are expressed as means Ϯ SE of millimeter of mercury, milliequivalents per liter, and milliliters.</s><s>*P Ͻ 0.05, **P Ͻ 0.01 ob/ob treated vs. ob/ob vehicle group; ob/ob vehicle, n ϭ 5-7; ob/ob treated, n ϭ 5 to 6.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>0 0.00007 0.00014 0.00021 0.00028 0.00035 Control Amastatin (10 μM) Glu-βNA Hydrolysis (μM/min)/ μl serum) (A.F.U.) ob/+ ob/ob *** *** A 0 1.4 2.8 4.2 5.6 7 Heart Kidney Lung Liver Skeletal Muscle White Adipose Tissue Glu-βNA Hydrolysis (μM/min)/ mg tissue) (A.F.U.) ob/+ ob/ob *** * B 0 0.2 0.4 0.6 0.8 1 1.2 1.4 Heart Kidney Lung Liver Skeletal Muscle White Adipose Tissue mRNA expression (APA/β-actin) (a.u.) ob/+ ob/ob * *** C</head><label></label><figDesc><div><p><s>Fig.1.</s><s>Aminopeptidase A (APA) activity in serum and tissues of ob/ob and ob/ϩ mice.</s><s>APA activity in the serum ob/ob and ob/ϩ mice in the absence or presence of 10 M amastatin (A).</s><s>APA activity (B) and mRNA quantification (C) in heart, kidney, lung, liver, skeletal muscle, and white adipose tissue in ob/ob and ob/ϩ mice are shown.</s><s>Data are expressed as means Ϯ SE of glutamyl ␤-naphtylamine substrate hydrolysis or the 2 -⌬Ct parameter represents the relative expression between APA and ␤-actin genes.</s><s>AFU, arbitrary fluorescence units; au, arbitrary units.</s></p></div></figDesc><table><row><cell>H438</cell><cell>HIGH AMINOPEPTIDASE A ACTIVITY IN OB/OB MICE</cell></row><row><cell cols="2">primer 5=-CATCTTTGTGGTGGGAATATTTGG-3= and reverse</cell></row><row><cell cols="2">primer 5=-TGGCCACAGTCTTCAGCTTC-3=; murine AT 2 receptor</cell></row><row><cell cols="2">forward primer 5=-TCCCCTTGTTTGGTGTATGG-3= and reverse</cell></row><row><cell cols="2">primer 5=-TTTCATTAAGGCAATCCCAGC-3=. The expression lev-</cell></row><row><cell cols="2">els were obtained from the cycle threshold (Ct) associated with the</cell></row><row><cell cols="2">exponential growth of the PCR products. Quantitative values for</cell></row><row><cell cols="2">mRNA expression were obtained by the parameter 2 Ϫ⌬Ct .</cell></row><row><cell></cell><cell>ob,</cell></row><row><cell>n ϭ 6.</cell><cell></cell></row></table><note><p><s>*P Ͻ 0.05 and ***P Ͻ 0.001 ob/ob vs. ob/ϩ group; ob/ϩ, n ϭ 7; ob/</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>9.00E-05 1.80E-04 2.70E-04 3.60E-04 Control Leptin (200 ng/ml) Glu-βNA Hydrolysis (μM/min)/ μl serum) (A.F.U.) ob/+ ob/ob</head><label></label><figDesc></figDesc><table><row><cell>A</cell><cell>***</cell><cell>***</cell><cell>0.00028 0.00035</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.00021</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.00014</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0.00007</cell></row><row><cell></cell><cell></cell><cell></cell><cell>0</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Glu-βNA Hydrolysis (μM/min)/ μl serum) (A.F.U.) ob/ob mice Saline Leptin B 0 0.00009 0.00018 0.00027 0.00036 0.00045 Glu-βNA Hydrolysis (μM/min)/ μl serum) (A.F.U.) ob/ob mice</head><label></label><figDesc></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>C</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>**</cell><cell>Saline Leptin</cell></row><row><cell>D Glu-βNA Hydrolysis (μM/min)/ mg kidney) (A.F.U.)</cell><cell>0 1.6 3.2 4.8 6.4</cell><cell>ob/ob mice</cell><cell>Saline Leptin</cell><cell>Weight (g)</cell><cell>0 10 60 50 20 30 40</cell><cell>Before</cell><cell>After</cell><cell>Saline Leptin</cell></row></table><note><p><s>* E Fig. 2. APA activity in serum of ob/ob mice after in vitro and in vivo leptin treatment.</s><s>A: APA activity in control serum or incubated with leptin.</s><s>B: APA activity in the serum of ob/ob mice after acute intravenous treatment for 1 h with saline or leptin (1 mg/kg).</s><s>APA activity in the serum of ob/ob mice (C) or kidney tissue (D) after chronic treatment with saline or leptin (1 mg/kg ip) for 21 days are shown.</s><s>E: body weight of ob/ob mice after chronic treatment with saline or leptin (1 mg/kg) for 21 days.</s><s>Data are expressed as means Ϯ SE of glutamyl ␤-naphtylamine substrate hydrolysis or grams.</s><s>*P Ͻ 0.05 and **P Ͻ 0.01 ob/ob saline vs. ob/ob leptin group; ***P Ͻ 0.001 ob/ob vs. ob/ϩ group; ob/ϩ, n ϭ 4 -6; ob/ob, n ϭ 6. H439 HIGH AMINOPEPTIDASE A ACTIVITY IN OB/OB MICE tion and urine volume were collected in metabolic cages for 24 h.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>APA activity in apoEϪ/Ϫ mice Group Body Weight, g Cholesterol, mg/dl Serum APA Activity, (M/min)/l Control 28.68 Ϯ 0.57 176.9 Ϯ 16.71 1.08 Ϯ 0.15 ϫ 10 Ϫ4 apoE Ϫ/Ϫ 29.84 Ϯ 0.75 483.1 Ϯ 40.96* 0.92 Ϯ 0.07 ϫ 10 Ϫ4 Values are means Ϯ SE of glutamyl ␤-naphtylamine substrate hydrolysis, milligram per deciliter or gram from n ϭ 5 mice per group.</s><s>APA, aminopeptidase A; apoE Ϫ/Ϫ , apolipoprotein E. *P Ͻ 0.05 apoE Ϫ/Ϫ vs. control group.</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head></head><label></label><figDesc><div><p><s>Data are expressed as means Ϯ SE of millimeter of mercury, milliequivalents per liter, and milliliters; the 2 Ϫ⌬Ct parameter represents the relative expression of AT1, AT2 receptors, and ␤-actin genes, and picomoles per milliliter.</s></p></div></figDesc><table><row><cell>H442</cell><cell></cell><cell cols="2">HIGH AMINOPEPTIDASE A ACTIVITY IN OB/OB MICE</cell></row><row><cell>ob/+</cell><cell>ob/ob</cell><cell>ob/+</cell><cell>ob/ob</cell></row><row><cell></cell><cell></cell><cell></cell><cell>ob/+</cell><cell>ob/ob</cell></row><row><cell cols="3">BP control in ob/ob mice. APA inhibition also induced BP</cell><cell>G</cell><cell>*</cell></row><row><cell cols="3">increase, however, with no changes in natriuresis. Although</cell><cell></cell></row><row><cell cols="3">sodium excretion was not affected by amastatin treatment, we</cell><cell></cell></row><row><cell cols="3">could consider that BP increase was caused by the inhibition</cell><cell></cell></row><row><cell cols="3">of ANG-II metabolization into ANG III. In this way, increased</cell><cell></cell></row><row><cell cols="3">ANG-II availability would lead to increased AT 1 activation</cell><cell></cell></row><row><cell cols="3">and BP elevation. Thus, taking into account that amastatin can</cell><cell></cell></row><row><cell cols="3">ob/+ also inhibit others aminopeptidases besides APA, such as APN, ob/ob we assume that this treatment was not effective in activating</cell><cell>ob/+</cell><cell>ob/ob</cell></row><row><cell cols="5">Fig. 5. Blood pressure, sodium excretion, and kidney parameters in ob/ob and ob/ϩ mice. Mean arterial pressure (A), sodium excretion (B), urine volume (C), the ANG III-AT 2 receptor axis. In addition, previous studies water consumption (D), mRNA expression of AT2 (E) and AT1 receptors in kidney (F), and guanosine 3=,5=-cyclic monophosphate (cGMP) levels in kidney (G). demonstrated that amastatin or PD123319 treatments presented are shown. 5 no effects in blood pressure values in control rodents (2, 23,</cell></row><row><cell>to 6.</cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>*P Ͻ 0.05, ***P Ͻ 0.001 ob/ob vs. ob/ϩ group; ob/ϩ, n ϭ 5-7; ob/ob, n ϭ</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">AJP-Heart Circ Physiol• doi:10.1152/ajpheart.00485.2016 • www.ajpheart.org Downloaded from journals.physiology.org/journal/ajpheart (176.172.000.127) on May 17, 2022.</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Rapid onset of renal sympathetic nerve activation in rabbits fed a high-fat diet</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Armitage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Prior</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Barzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Eikelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Head</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.111.190413</idno>
		<idno>doi:10.1161/ HYPERTENSIONAHA.111</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="163" to="171" />
			<date type="published" when="2012">2012. 190413</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Effects of candesartan and PD123319 on responses to angiotensin II in the anesthetized mouse</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Bivalacqua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dalal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Champion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Kadowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="S98" to="S100" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Orally active aminopeptidase a inhibitors reduce blood pressure: a new strategy for treating hypertension</title>
		<author>
			<persName><forename type="first">L</forename><surname>Bodineau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Frugière</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Marc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Inguimbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fassot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Balavoine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Roques</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Llorens-Cortes</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.107.098772</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1318" to="1325" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Boustany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bharadwaj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Daugherty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Randall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Cassis</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpregu.00265.2004</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Regul Integr Comp Physiol</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="page" from="R943" to="R949" />
			<date type="published" when="2004">2004. 2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">AT1-receptor antagonism reverses the blood pressure elevation associated with dietinduced obesity</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Boustany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Randall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Cassis</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpregu.00507.2004</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Regul Integr Comp Physiol</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="R181" to="R186" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Chronic cardiovascular and renal actions of leptin: role of adrenergic activity</title>
		<author>
			<persName><forename type="first">M</forename><surname>Carlyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">B</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Kuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hall</surname></persName>
		</author>
		<idno type="DOI">10.1161/hy0202.104398</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="496" to="501" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Do Carmo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Da Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Dubinion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hall</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.110.161349</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="918" to="926" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cutler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Sorlie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wolz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Thom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Fields</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Roccella</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.108.113357</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="818" to="827" />
			<date type="published" when="1988">1988-1994 and 1999-2004. 2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants</title>
		<author>
			<persName><forename type="first">G</forename><surname>Danaei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Finucane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Paciorek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Cowan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Farzadfar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Riley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ezzati</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736%2810%2962036-3</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">377</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="62036" to="62039" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Proteins of the kidney microvillar membrane. Aspartate aminopeptidase: purification by immunoadsorbent chromatography and properties of the detergent-and proteinase-solubilized forms</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Danielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Norén</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sjöström</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ingram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Kenny</surname></persName>
		</author>
		<idno type="DOI">10.1042/bj1890591</idno>
		<idno>doi:10. 1042/bj1890591</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="page" from="591" to="603" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Sympathetic nervous system behavior in human obesity</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Davy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Orr</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neubiorev.2008.05.024</idno>
		<idno>doi:10.1016/j. neubiorev.2008.05.024</idno>
	</analytic>
	<monogr>
		<title level="j">Neurosci Biobehav Rev</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="116" to="124" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Development of hypertension in a rat model of diet-induced obesity</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Dobrian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Prewitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Lauterio</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.HYP.35.4.1009</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1009" to="1015" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Physiologic regulation of arterial pressure. An overview</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Dustan</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.HYP.4.5_Pt_2.III62</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="I62" to="I67" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Brain reninangiotensin system blockade by systemically active aminopeptidase a inhibitors: a potential treatment of salt-dependent hypertension</title>
		<author>
			<persName><forename type="first">Fournie-Zaluski M-C</forename><surname>Fassot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Valentin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Djordjijevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Reaux-Le</forename><surname>Goazigo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Corvol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Roques</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Llorens-Cortes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0402312101</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="7775" to="7780" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">A longitudinal hormonal profile of the genetically obese mouse</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Garthwaite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Martinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Tseng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Hagen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Menahan</surname></persName>
		</author>
		<idno type="DOI">10.1210/endo-107-3-671</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="671" to="676" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">a mammalian peptidase specific for the hydrolysis of N-terminal alpha-L-glutamyl and aspartyl residues</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Glenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Mcmillan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Folk</surname></persName>
		</author>
		<idno type="DOI">10.1038/194867a0</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">194</biblScope>
			<biblScope unit="page">867</biblScope>
			<date type="published" when="1962">1962</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The kidney, hypertension, and obesity</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hall</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.HYP.0000052314.95497.78</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="625" to="633" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Da Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Do Carmo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dubinion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hamza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Munusamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Stec</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.R110.113175</idno>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="page" from="17271" to="17276" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Leptin regulates ACE activity in mice</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Hilzendeger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Morais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Todiras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Plehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Da Costa Goncalves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Qadri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Araujo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Nakaie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Casarini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Carmona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Pesquero</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00109-010-0649-7</idno>
	</analytic>
	<monogr>
		<title level="j">J Mol Med (Berl)</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="899" to="907" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Do cardiac and perivascular adipose tissue play a role in atherosclerosis?</title>
		<author>
			<persName><forename type="first">G</forename><surname>Iacobellis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Sharma</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11892-008-0005-2</idno>
	</analytic>
	<monogr>
		<title level="j">Curr Diab Rep</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="20" to="24" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The effect of recombinant aminopeptidase a on hypertension in spontaneously hypertensive rats: its effect in comparison with candesartan</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ishii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hattori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Numaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tsujimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ishiura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Murohara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mizutani</surname></persName>
		</author>
		<idno type="DOI">10.1055/s-0028-1083783</idno>
	</analytic>
	<monogr>
		<title level="j">Horm Metab Res</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="887" to="891" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Jayasooriya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Mathai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Begg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Denton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cameron-Smith</forename></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Egan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Mckinley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Rodger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Sinclair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Wark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Weisinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Jois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Weisinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0802690105</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="6531" to="6536" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergicdependent in normotensive and hypertensive rat strains</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Harding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Wright</surname></persName>
		</author>
		<idno type="DOI">10.1016/0006-8993%2889%2990429-0</idno>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">490</biblScope>
			<biblScope unit="page" from="48" to="55" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Adipose and height growth through childhood and blood pressure status in a large prospective cohort study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Charakida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Falaschetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Hingorani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Finer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Masi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Donald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Lawlor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Deanfield</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.111.187716</idno>
		<idno>doi:10.1161/ HYPERTENSIONAHA.111.187716</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="919" to="925" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Kemp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Rottkamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Howell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Shao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Navar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Padia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Carey</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.112.191403</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="387" to="395" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Contrasting blood pressure effects of obesity in leptindeficient ob/ob mice and agouti yellow obese mice</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Mark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Shaffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Correia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Sigmund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Haynes</surname></persName>
		</author>
		<idno type="DOI">10.1097/00004872-199917121-00026</idno>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<date type="published" when="1949">1949 -1953, 1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Sex differences and in vitro effects of steroids on serum aminopeptidase activities</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ramirez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Prieto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Alba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ramirez</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0196-9781%2898%2900095-3</idno>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1637" to="1640" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Metabolic, nutritional and endocrine studies of the hereditary obesity-diabetes syndrome of mice and mechanism of its development</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Bates</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Dickie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Metabolism</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="9" to="21" />
			<date type="published" when="1953">1953</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice</title>
		<author>
			<persName><forename type="first">T</forename><surname>Mitsui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nomura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Okada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakashima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Murata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Takeuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kuno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nagasaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>O-Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mizutani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="57" to="62" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Purification of aminopeptidase A in human serum and degradation of angiotensin II by the purified enzyme</title>
		<author>
			<persName><forename type="first">I</forename><surname>Nagatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nagatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Glenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Mehl</surname></persName>
		</author>
		<idno type="DOI">10.1016/0005-2744%2870%2990058-6</idno>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">198</biblScope>
			<biblScope unit="page" from="255" to="270" />
			<date type="published" when="1970">1970</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Effects of the obese gene product on body weight regulation in ob/ob mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Pelleymounter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Cullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Winters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Boone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Collins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">269</biblScope>
			<biblScope unit="page" from="540" to="543" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Premaratna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Manickam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Begg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Rayment</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hafandi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cameron-Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Weisinger</surname></persName>
		</author>
		<idno type="DOI">10.1038/ijo.2011.95</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Obes</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="233" to="243" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Aminopeptidase a inhibitors as potential central antihypertensive agents</title>
		<author>
			<persName><forename type="first">A</forename><surname>Reaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Fournie-Zaluski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Roques</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Corvol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Llorens-Cortes</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.96.23.13415</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="13415" to="13420" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Da Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Kuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hall</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.HYP.0000128421.23499.b9</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1312" to="1317" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Leptin mediates the increase in blood pressure associated with obesity</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Simonds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Pryor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ravussin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Greenway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dileone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bassi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Elmquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Keogh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Henning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Myers</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Licinio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Enriori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>O'rahilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Sternson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Grove</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Spanswick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Farooqi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Cowley</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2014.10.058</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="1404" to="1416" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">H444</forename><surname>High</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Aminopeptidase A Activity In Ob/Ob</forename><surname>Mice</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Ajp-Heart Circ</forename><surname>Physiol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">•</forename><surname>Doi</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpheart.00485.2016•www.ajpheart.orgDownloadedfromjournals.physiology.org/journal/ajpheart(176.172.000.127</idno>
		<ptr target="10.1152/ajpheart.00485.2016•www.ajpheart.orgDownloadedfromjournals.physiology.org/journal/ajpheart(176.172.000.127" />
		<imprint>
			<date type="published" when="2022-05-17">May 17, 2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Siragy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De Gasparo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Carey</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.HYP.35.5.1074</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1074" to="1077" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Tallam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Da Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hall</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.HYP.0000227966.36744.d9</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="58" to="64" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Water and sodium intake of wild and New Zealand Rabbits following angiotensin</title>
		<author>
			<persName><forename type="first">E</forename><surname>Tarjan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Denton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Mcburnie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Weisinger</surname></persName>
		</author>
		<idno type="DOI">10.1016/0196-9781%2888%2990182-9</idno>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="677" to="679" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Glutamyl aminopeptidase (aminopeptidase a), the BP-1/6C3 antigen</title>
		<author>
			<persName><forename type="first">S</forename><surname>Wilk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Healy</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0960-5428%2805%2980021-X</idno>
		<idno>doi:10.1016/ S0960-5428(05</idno>
	</analytic>
	<monogr>
		<title level="j">Adv Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">80021</biblScope>
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<monogr>
		<title level="m" type="main">World Health Organization. Primary Prevention of Cardiovascular Disease</title>
		<imprint>
			<date type="published" when="2007">2007</date>
			<publisher>World Health Organization</publisher>
			<pubPlace>Geneva, Switzerland</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<monogr>
		<title level="m" type="main">World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks</title>
		<imprint>
			<date type="published" when="2009">2009</date>
			<pubPlace>Geneva, Switzerland</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">World Health Organization</title>
	</analytic>
	<monogr>
		<title level="j">World Health Organization. Global Status Report on Noncommunicable Diseases</title>
		<imprint>
			<date type="published" when="2010">2010. 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice</title>
		<author>
			<persName><forename type="first">F</forename><surname>Yiannikouris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gupte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Putnam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Thatcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Charnigo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Rateri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Daugherty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Cassis</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.112.192690</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1524" to="1530" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Aminopeptidase A Activity In Ob/Ob</forename><surname>High</surname></persName>
		</author>
		<author>
			<persName><surname>Mice</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
